Stop using nowDrug recall · FDA · Published November 19, 2021
Lupin Tydemy: Subpotent Drug Recall - Stop Using Now
Lupin Pharmaceuticals recalls Tydemy birth control tablets due to subpotent drug levels. Affected lots expire May 2022. Stop using immediately to avoid potential ineffective contraception.
“Lupin Tydemy: Subpotent Drug Recall - Stop Using Now.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35529-lupin-tydemy-subpotent-drug-recall-stop-using-now. Based on FDA recall #D-0264-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0264-2022%22&limit=1).
Lupin Pharmaceuticals Inc. recalled Tydemy tablets nationwide due to subpotent drug risks, the Food and Drug Administration said on Nov. 19, 2021. The voluntary Class III recall involved 4,113 cartons distributed across the United States.
The recall addresses the hazard of subpotent drug, meaning the medication may not contain the expected potency of active ingredients. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Lupin Pharmaceuticals Inc. has 90 other recalls on record since Jan. 31, 2013. Other recent recalls include the Lupin Clobetasol Cream Recall (Aug. 3, 2026), the Lupin Glucagon Emergency Kit Recall (June 23, 2026), and the Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026). Other recent recalls of similar products include the Unichem busPIRone 5mg Tablets Recall (April 13, 2026), the Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), and the Accord Healthcare Levothyroxine Tablets Recall (Aug. 6, 2026).
How to tell if you have this one
Check the individual wallet NDC 68180-904-11 and carton NDC 68180-904-13. The lot numbers L000784 or L000785 with expiration date May 2022 indicate the recalled product.
Brand
Lupin Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Now
Immediately stop using the recalled Tydemy tablets to prevent potential ineffective contraception.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0264-2022 (November 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0264-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.